Research Article

Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease

Volume: 39 Number: 3 September 1, 2012
  • Ali Kutlucan
  • Sevket Ercan Tunc
  • Davut Baltacı
  • Mehmet Sahin
  • Mustafa Ozsahin
  • Recep Sütcü
  • Fatih Ermis
  • Harun Süslü
EN TR

Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease

Abstract

Objectives: Osteoporosis is commonly developed due to
natural course of Behçet’s disease (BD) and therapeutic
agents. It was aimed to investigate levels of osteoprotegerin
and TNF-α (tumor necrosis factor), and bone mineral density
(BMD) and correlation between them in BD.
Materials and methods: The study included two groups
as the study and the control group. Serum levels of TNF-α,
osteoprotegerin, osteocalcine, erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), and urinary creatinine and
deoxypyridinoline along with BMD level were evaluated and
compared. Correlation between TNF-α and osteoprotegerin
level was investigated.
Results: The study enrolled 41 BD patients and 36 agedmatched control subjects. Mean age was 42.26±11.64 and
41.66±70.99, in the study and control groups, respectively.
There was no significant difference in body mass index
(BMI) of subjects between groups (p>0.05). Level of TNF-α
(p<0.001), deoxypyridinoline (p<0.001) and osteocalcine
(p=0.041) was significantly higher in the study group compared to the control group. Osteoprotegerin was lower in
BD patients, but the difference was not significant (p>0.05).
Urinary deoxypyridinoline/ urinary creatinine ratio in patients
with BD was significantly higher than those in control group
(p=0.030). Patients had significantly lower BMD comparfed
to the control group, except L2-L4 vertebral area (p<0.001,
p<0.001, p=0.035, p<0.001, p=0.012, p<0.001, p<0.001 and
p=0.111, respectively). No correlation was found between
TNF-α and osteoprotegerin.
Conclusions: The present study indicated that TNF-α and
BMD was negatively correlated with each other and TNF-α
had an effect on osteoporotic process in patients with BD.
Osteoprotegerin level was not decreased, and not correlated
with TNF-α.

Keywords

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Ali Kutlucan This is me

Sevket Ercan Tunc This is me

Davut Baltacı This is me

Mehmet Sahin This is me

Mustafa Ozsahin This is me

Recep Sütcü This is me

Fatih Ermis This is me

Harun Süslü This is me

Publication Date

September 1, 2012

Submission Date

March 2, 2015

Acceptance Date

-

Published in Issue

Year 2012 Volume: 39 Number: 3

APA
Kutlucan, A., Tunc, S. E., Baltacı, D., Sahin, M., Ozsahin, M., Sütcü, R., Ermis, F., & Süslü, H. (2012). Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal, 39(3), 325-330. https://doi.org/10.5798/diclemedj.0921.2012.03.0152
AMA
1.Kutlucan A, Tunc SE, Baltacı D, et al. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal. 2012;39(3):325-330. doi:10.5798/diclemedj.0921.2012.03.0152
Chicago
Kutlucan, Ali, Sevket Ercan Tunc, Davut Baltacı, et al. 2012. “Serum Levels of TNF-α and Osteoprotegerin and Bone Mineral Density in Patients With Behçet’s Disease”. Dicle Medical Journal 39 (3): 325-30. https://doi.org/10.5798/diclemedj.0921.2012.03.0152.
EndNote
Kutlucan A, Tunc SE, Baltacı D, Sahin M, Ozsahin M, Sütcü R, Ermis F, Süslü H (September 1, 2012) Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal 39 3 325–330.
IEEE
[1]A. Kutlucan et al., “Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease”, Dicle Medical Journal, vol. 39, no. 3, pp. 325–330, Sept. 2012, doi: 10.5798/diclemedj.0921.2012.03.0152.
ISNAD
Kutlucan, Ali - Tunc, Sevket Ercan - Baltacı, Davut - Sahin, Mehmet - Ozsahin, Mustafa - Sütcü, Recep - Ermis, Fatih - Süslü, Harun. “Serum Levels of TNF-α and Osteoprotegerin and Bone Mineral Density in Patients With Behçet’s Disease”. Dicle Medical Journal 39/3 (September 1, 2012): 325-330. https://doi.org/10.5798/diclemedj.0921.2012.03.0152.
JAMA
1.Kutlucan A, Tunc SE, Baltacı D, Sahin M, Ozsahin M, Sütcü R, Ermis F, Süslü H. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal. 2012;39:325–330.
MLA
Kutlucan, Ali, et al. “Serum Levels of TNF-α and Osteoprotegerin and Bone Mineral Density in Patients With Behçet’s Disease”. Dicle Medical Journal, vol. 39, no. 3, Sept. 2012, pp. 325-30, doi:10.5798/diclemedj.0921.2012.03.0152.
Vancouver
1.Ali Kutlucan, Sevket Ercan Tunc, Davut Baltacı, Mehmet Sahin, Mustafa Ozsahin, Recep Sütcü, Fatih Ermis, Harun Süslü. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal. 2012 Sep. 1;39(3):325-30. doi:10.5798/diclemedj.0921.2012.03.0152